Education
About Us
Working with TipRanks
Follow Us
Achieve Life Sciences (ACHV)
NASDAQ:ACHV
Total Valuation
Achieve Life Sciences has a market cap or net worth of $237.42M. The enterprise value is $122.55M.
Market Cap$237.42M
Enterprise Value$122.55M
Share Statistics
Achieve Life Sciences has 53,233,990 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,233,990
Owned by Insiders1.68%
Owned by Institutions12.73%
Financial Efficiency
Achieve Life Sciences’s return on equity (ROE) is -1.91 and return on invested capital (ROIC) is -121.86%.
Return on Equity (ROE)-1.91
Return on Assets (ROA)-1.03
Return on Invested Capital (ROIC)-121.86%
Return on Capital Employed (ROCE)-1.22
Revenue Per Employee0.00
Profits Per Employee-1.59M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Achieve Life Sciences is ―. Achieve Life Sciences’s PEG ratio is 0.16.
PE Ratio―
PS Ratio0.00
PB Ratio5.40
Price to Fair Value5.40
Price to FCF-3.79
Price to Operating Cash Flow-5.79
PEG Ratio0.16
Income Statement
In the last 12 months, Achieve Life Sciences had revenue of 0.00 and earned -39.83M in profits. Earnings per share was -1.24.
Revenue0.00
Gross Profit-229.00K
Operating Income-39.07M
Pretax Income-39.83M
Net Income-39.83M
EBITDA-37.42M
Earnings Per Share (EPS)-1.24
Cash Flow
In the last 12 months, operating cash flow was -40.68M and capital expenditures 0.00, giving a free cash flow of -40.68M billion.
Operating Cash Flow-40.68M
Free Cash Flow-40.68M
Free Cash Flow per Share-0.76
Dividends & Yields
Achieve Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.95
52-Week Price Change17.37%
50-Day Moving Average4.57
200-Day Moving Average3.26
Relative Strength Index (RSI)49.74
Average Volume (3m)550.75K
Important Dates
Achieve Life Sciences upcoming earnings date is Mar 12, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Achieve Life Sciences as a current ratio of 5.46, with Debt / Equity ratio of 29.62%
Current Ratio5.46
Quick Ratio5.46
Debt to Market Cap0.09
Net Debt to EBITDA0.07
Interest Coverage Ratio-17.92
Taxes
In the past 12 months, Achieve Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Achieve Life Sciences EV to EBITDA ratio is -2.94, with an EV/FCF ratio of -3.70.
EV to Sales0.00
EV to EBITDA-2.94
EV to Free Cash Flow-3.70
EV to Operating Cash Flow-3.70
Balance Sheet
Achieve Life Sciences has $48.11M in cash and marketable securities with $9.96M in debt, giving a net cash position of $38.16M billion.
Cash & Marketable Securities$48.11M
Total Debt$9.96M
Net Cash$38.16M
Net Cash Per Share$0.72
Tangible Book Value Per Share$0.59
Margins
Gross margin is -1.32%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-1.32%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Achieve Life Sciences is $15.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.33
Price Target Upside243.72% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast-22.06%